Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
36%(4 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_2
2
17%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(11)
Other(1)

Detailed Status

Completed11
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (16.7%)
N/A10 (83.3%)

Trials by Status

completed1192%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12